![]() |
市场调查报告书
商品编码
1426975
神经刺激设备市场规模 - 依产品(深部脑、胃电、脊髓、荐神经、迷走神经刺激器)、按应用(癫痫、疼痛管理、特发性震颤、尿失禁和大便失禁)及预测,2023 - 2032Neurostimulation Devices Market Size - By Product (Deep Brain, Gastric Electric, Spinal Cord, Sacral Nerve, Vagus Nerve Stimulator), By Application (Epilepsy, Pain Management, Essential Tremor, Urinary & Fecal Incontinence) & Forecast, 2023 - 2032 |
在神经系统疾病盛行率不断上升和人口老化不断增长的推动下,神经刺激设备市场预计在 2024 年和 2032 年期间CAGR将超过 12.2%。根据世界中风组织-柳叶刀神经病学委员会的资料,预计到2050年,死于中风的人数将增加50%,达到每年近970万人。
技术创新和对有效治疗方案不断增长的需求是市场成长的另一个驱动力。神经刺激装置已成为解决各种神经系统疾病的关键解决方案。
整个神经刺激设备市场根据产品、应用和地区进行分类。
预计到2032 年,深部脑部刺激器(DBS) 领域将大幅成长。这项创新技术涉及使用植入设备,为大脑的特定区域提供电刺激,为患有帕金森氏症等神经系统疾病的患者提供缓解。特发性震颤、癫痫。近年来,随着刺激模式精度和客製化的提高、治疗效果的提高和副作用的最小化,取得了重大进展,推动了对深部脑部刺激器的需求。
随着神经刺激设备成为控制症状和改善患者生活品质的突破,预计到 2032 年,帕金森氏症领域将在市场上产生大量收入。帕金森氏症的特征是震颤、僵硬和平衡受损,给受影响的人带来了巨大的挑战。神经刺激装置已被证明可以有效缓解运动症状并提高帕金森氏症患者的整体健康状况。随着该领域研发的不断进步,帕金森氏症应用中的产品采用率将会增加。
受医疗保健支出增加、有利的报销政策以及神经系统疾病盛行率上升的推动,到 2032 年,欧洲神经刺激设备市场规模将大幅扩大。支持性的监管环境,加上主要参与者和研究机构之间的合作,正在促进创新并推动先进神经刺激技术的发展,塑造区域市场前景。
Neurostimulation devices market is anticipated to record more than 12.2% CAGR during 2024 and 2032, driven by the increasing prevalence of neurological disorders and a growing aging population. According to the data from A World Stroke Organization - Lancet Neurology Commission, the number of people dying from a stroke is expected to increase by 50%, reaching nearly 9.7 million deaths each year by 2050.
The technological innovations and a rising demand for effective treatment options are another driving force for market growth. Neurostimulation devices have emerged as a pivotal solution in addressing various neurological conditions.
The overall neurostimulation devices market is classified based on product, application, and region.
The Deep Brain Stimulator (DBS) segment is predicted to witness substantial growth through 2032. This innovative technology involves the use of implanted devices that deliver electrical stimulation to specific areas of the brain, offering relief for patients suffering from neurological disorders such as Parkinson's disease, essential tremor, and epilepsy. The significant advancements in recent years, with improved precision and customization of stimulation patterns, enhancing therapeutic outcomes and minimizing side effects are pushing the demand for deep brain stimulators.
The Parkinson's disease segment is expected to generate massive revenues in the market by 2032 as neurostimulation devices have emerged as a breakthrough in managing symptoms and improving the quality of life for patients. Parkinson's disease, characterized by tremors, stiffness, and impaired balance, poses significant challenges for those affected. Neurostimulation devices have proven to be effective in alleviating motor symptoms and enhancing the overall well-being of Parkinson's patients. As R&D in this field continue to advance, there will be increased product adoption in Parkinson's disease applications.
Europe neurostimulation devices market size will expand significantly through 2032, driven by the increasing healthcare expenditure, favorable reimbursement policies, and a rising prevalence of neurological disorders. The supportive regulatory environment, in consort with collaborations between key players and research institutions are fostering innovation and driving the development of advanced neurostimulation technologies, shaping the regional market outlook.